Close Menu
Technology Mag

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Meta is opening up its smart glasses to developers

    September 18, 2025

    SpaceX Targets 2026 to Test Orbital Flight for Next-Gen Starship Vehicle

    September 18, 2025

    Why your outdoorsy friend suddenly has a gummy bear power bank

    September 18, 2025
    Facebook X (Twitter) Instagram
    Subscribe
    Technology Mag
    Facebook X (Twitter) Instagram YouTube
    • Home
    • News
    • Business
    • Games
    • Gear
    • Reviews
    • Science
    • Security
    • Trending
    • Press Release
    Technology Mag
    Home » The Gut Might Hold the Key to Treating Long Covid in Kids
    Science

    The Gut Might Hold the Key to Treating Long Covid in Kids

    News RoomBy News RoomOctober 1, 20243 Mins Read
    Facebook Twitter Pinterest LinkedIn Reddit WhatsApp Email

    Yonker and her colleagues will administer larazotide to 32 patients between the ages of 7 and 21, who will take the drug for eight weeks; a further 16 patients will receive a placebo. To qualify for the trial, patients must have a detectable presence of the Covid-19 spike protein in their blood. The intention is to see whether reducing intestinal permeability can make a noticeable difference to the young patients’ symptoms and quality of life.

    Running such a trial has not been straightforward. “It began last year, but we had to put it on pause for a few months because of staffing and drug supply issues,” says Yonker. “One of the requirements is that we need to ensure that the spike protein is present in the blood, which can involve multiple blood draws from these children, which takes time. Because of this I expect it will take one to two more years to recruit all the patients we need, but I would love to move faster.”

    The results, when they emerge, will help researchers determine whether a leaky gut is likely to be a major cause of disease in at least a subset of patients, and whether larazotide should be trialed more widely as a possible treatment.

    There could be other gut-related involvement: Brodin believes that in some children, the virus lingers in the gut rather than being fully excreted, enabling it to actively damage the intestinal wall and contributing to gastrointestinal problems. He suspects that this viral persistence can then induce an autoimmune reaction in the bloodstream, causing further symptoms.

    Yonker’s trial is also encouraging other pediatric long Covid researchers to initiate their own trials, exploring other theories behind the condition. Danilo Buonsenso, a pediatrician at the Gemelli University Hospital in Rome who conducted the first study examining whether children were developing long Covid, described the study as fascinating. He is now trying to get funding for an ambitious trial testing multiple treatments.

    Buonsenso’s work includes studies suggesting that blood clots, as well as inflammation within the lining of the blood vessels known as the endothelium, may play a role in driving certain symptoms. Separately, he led a study that found some children with long Covid also struggle with a condition called postural tachycardia syndrome (POTS) that affects many adults with long Covid, too.

    “In my opinion, there will not be a single drug that will solve long Covid, as multiple things are being documented,” he says. “We need to investigate the role of low-dose anticoagulants with known effects on reducing endothelial inflammation. But we also need to look at specific drugs for POTS and specific medications for the neurocognitive symptoms like chronic pain and headache.”

    Meanwhile, Yonker’s focus on the gut represents a crucial first step. Given the desperation of children suffering from the condition, and their parents, she is hopeful that if her trial proves successful, it will provide an evidence-based treatment option specifically for children. “I think it’s extremely important to advocate for timely treatment advances in children suffering from long Covid rather than wait for trickle-down guidance, based on what we see from trials in adults,” she says.

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email
    Previous ArticleNintendo has reportedly shut down Ryujinx, the Switch emulator that was supposedly immune
    Next Article Snap employees were well aware of the app’s child safety issues, newly unsealed complaint says

    Related Posts

    SpaceX Targets 2026 to Test Orbital Flight for Next-Gen Starship Vehicle

    September 18, 2025

    Moderna CEO Responds to RFK Jr.’s Crusade Against the Covid-19 Vaccine

    September 18, 2025

    Big Businesses Are Doing Carbon Dioxide Removal All Wrong

    September 18, 2025

    Whole-Genome Sequencing Will Change Pregnancy

    September 18, 2025

    The Quest to Find the Longest-Running Simple Computer Program

    September 18, 2025

    The Next Era of Gene Editing Will Be Disease Agnostic

    September 17, 2025
    Our Picks

    SpaceX Targets 2026 to Test Orbital Flight for Next-Gen Starship Vehicle

    September 18, 2025

    Why your outdoorsy friend suddenly has a gummy bear power bank

    September 18, 2025

    A DHS Data Hub Exposed Sensitive Intel to Thousands of Unauthorized Users

    September 18, 2025

    Intel says Arc GPUs will live on after Nvidia deal

    September 18, 2025
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Don't Miss
    News

    Nothing’s charging case Super Mic is a small upgrade to earbud audio

    By News RoomSeptember 18, 2025

    The microphones in your earbuds probably suck. You know, I know it, and apparently Nothing…

    Razer’s BlackShark V3 Pro Are the Best High-End Gaming Headphones

    September 18, 2025

    Nvidia and Intel’s $5 billion deal is apparently about eating AMD’s lunch

    September 18, 2025

    Nvidia CEO Jensen Huang Is Bananas for Google Gemini’s AI Image Generator

    September 18, 2025
    Facebook X (Twitter) Instagram Pinterest
    • Privacy Policy
    • Terms of use
    • Advertise
    • Contact
    © 2025 Technology Mag. All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.